Education
About Us
Working with TipRanks
Follow Us
NKGen Biotech (NKGN)
OTHER OTC:NKGN
Total Valuation
NKGen Biotech has a market cap or net worth of $15.72M. The enterprise value is ―.
Market Cap$15.72M
Enterprise Value―
Share Statistics
NKGen Biotech has 44,947,590 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding44,947,590
Owned by Insiders56.82%
Owned by Institutions1.99%
Financial Efficiency
NKGen Biotech’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee0.00
Profits Per Employee-1.32M
Employee Count63
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of NKGen Biotech is ―. NKGen Biotech’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, NKGen Biotech had revenue of 0.00 and earned -82.95M in profits. Earnings per share was -5.38.
Revenue0.00
Gross Profit-1.20M
Operating Income-29.75M
Pretax Income-82.95M
Net Income-82.95M
EBITDA-28.54M
Earnings Per Share (EPS)-5.38
Cash Flow
In the last 12 months, operating cash flow was -30.92M and capital expenditures -48.00K, giving a free cash flow of -30.97M billion.
Operating Cash Flow-30.92M
Free Cash Flow-30.97M
Free Cash Flow per Share-0.69
Dividends & Yields
NKGen Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change-79.53%
50-Day Moving Average0.17
200-Day Moving Average0.44
Relative Strength Index (RSI)73.04
Average Volume (3m)185.65K
Important Dates
NKGen Biotech upcoming earnings date is Nov 14, 2023, TBA Not Confirmed.
Last Earnings DateInvalid Date
Next Earnings DateNov 14, 2023
Ex-Dividend Date―
Financial Position
NKGen Biotech as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, NKGen Biotech has paid 7.00K in taxes.
Income Tax7.00K
Effective Tax Rate―
Enterprise Valuation
NKGen Biotech EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
NKGen Biotech has $79.00K in cash and marketable securities with $28.12M in debt, giving a net cash position of $28.04M billion.
Cash & Marketable Securities$79.00K
Total Debt$28.12M
Net Cash$28.04M
Net Cash Per Share$0.62
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for NKGen Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―